China SXT Pharmaceuticals (SXTC) Assets Average (2019 - 2025)
China SXT Pharmaceuticals (SXTC) has 7 years of Assets Average data on record, last reported at $22.4 million in Q1 2025.
- For Q1 2025, Assets Average fell 14.98% year-over-year to $22.4 million; the TTM value through Mar 2025 reached $22.4 million, down 14.98%, while the annual FY2025 figure was $22.4 million, 14.98% down from the prior year.
- Assets Average reached $22.4 million in Q1 2025 per SXTC's latest filing, down from $26.3 million in the prior quarter.
- Across five years, Assets Average topped out at $34.0 million in Q1 2022 and bottomed at $22.4 million in Q1 2025.
- Average Assets Average over 5 years is $28.5 million, with a median of $28.1 million recorded in 2021.
- Peak YoY movement for Assets Average: soared 43.59% in 2021, then fell 16.51% in 2024.
- A 5-year view of Assets Average shows it stood at $28.1 million in 2021, then increased by 21.06% to $34.0 million in 2022, then decreased by 7.33% to $31.6 million in 2023, then dropped by 16.51% to $26.3 million in 2024, then dropped by 14.98% to $22.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $22.4 million in Q1 2025, $26.3 million in Q1 2024, and $31.6 million in Q1 2023.